FDA Cites Repeat Offender Over Sterility, GMPs

Drug Industry Daily
A A
Ongoing quality issues at an Oklahoma outsourcing facility drew the ire of the FDA and a Form 483 for Qualgen—not a first for the company.

To View This Article:

Login

Subscribe To Drug Industry Daily